BACKGROUND: Slow spaced eating is associated with improved satiety and gut hormone responses in normal-weight participants. This crossover study compared the effect of slow and rapid eating patterns on hunger, fullness, glucose, insulin, and the appetite-related gut hormones peptide YY (PYY), glucagon-like peptide-1 (GLP-1), and ghrelin in overweight and obese participants with type 2 diabetes mellitus (T2DM). METHODS: 20 overweight and obese participants with T2DM on metformin were recruited. A test meal of 300 mL ice-cream was consumed in random order in two different sessions by each participant; meal duration was 5 or 30 min. Fullness and hunger as assessed by visual analog scales (VAS), and glucose, insulin, PYY, GLP-1, and ghrelin wer...
BACKGROUND: Longer oral processing decreases food intake. This can be attributed to greater oro-sens...
Aims/hypothesis: Glucagon-like peptide 1 (GLP-1) reduces appetite and energy intake in humans, where...
Background The promising postsurgical weight loss and remission of type 2 diabetes (T2D) from bariat...
BACKGROUND:Appetite and gastrointestinal hormones (GIHs) participate in energy homeostasis, feeding ...
Appetite and gastrointestinal hormones (GIHs) participate in energy homeostasis, feeding behavior an...
Background: Appetite and gastrointestinal hormones (GIHs) participate in energy homeostasis, feeding...
Background. The role of the hormones in eating behavior in the regulation of appetite has been well ...
BACKGROUND: Patients with type 1 diabetes face heightened risk of hypoglycemia after exercise. Subse...
Background: Patients with type 1 diabetes face heightened risk of hypoglycemia after exercise. Subse...
Purpose: Variations in specific oral processing behaviours may contribute to differences in glucose,...
Background: The search for biomarkers of appetite is very active. Objectives: The aims were to compa...
Background: Previous research showed that weight-reducing diets increase appetite sensations and/or ...
Aim: To assess the impact of the SGLT2 inhibitor empagliflozin (25mg once-daily), dietary energy res...
Aim To assess the impact of the sodium-glucose co-transporter-2 (SGLT2) inhibitor empagliflozin (25 ...
Aim: To compare a Mediterranean diet (MED) with a high-fibre vegetarian diet (HFV) in terms of hunge...
BACKGROUND: Longer oral processing decreases food intake. This can be attributed to greater oro-sens...
Aims/hypothesis: Glucagon-like peptide 1 (GLP-1) reduces appetite and energy intake in humans, where...
Background The promising postsurgical weight loss and remission of type 2 diabetes (T2D) from bariat...
BACKGROUND:Appetite and gastrointestinal hormones (GIHs) participate in energy homeostasis, feeding ...
Appetite and gastrointestinal hormones (GIHs) participate in energy homeostasis, feeding behavior an...
Background: Appetite and gastrointestinal hormones (GIHs) participate in energy homeostasis, feeding...
Background. The role of the hormones in eating behavior in the regulation of appetite has been well ...
BACKGROUND: Patients with type 1 diabetes face heightened risk of hypoglycemia after exercise. Subse...
Background: Patients with type 1 diabetes face heightened risk of hypoglycemia after exercise. Subse...
Purpose: Variations in specific oral processing behaviours may contribute to differences in glucose,...
Background: The search for biomarkers of appetite is very active. Objectives: The aims were to compa...
Background: Previous research showed that weight-reducing diets increase appetite sensations and/or ...
Aim: To assess the impact of the SGLT2 inhibitor empagliflozin (25mg once-daily), dietary energy res...
Aim To assess the impact of the sodium-glucose co-transporter-2 (SGLT2) inhibitor empagliflozin (25 ...
Aim: To compare a Mediterranean diet (MED) with a high-fibre vegetarian diet (HFV) in terms of hunge...
BACKGROUND: Longer oral processing decreases food intake. This can be attributed to greater oro-sens...
Aims/hypothesis: Glucagon-like peptide 1 (GLP-1) reduces appetite and energy intake in humans, where...
Background The promising postsurgical weight loss and remission of type 2 diabetes (T2D) from bariat...